Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.

× No keyword cloud information.

8 in total

1. STUDIES ON THE ADJUVANT ACTION OF BACTERIAL ENDOTOXINS ON ANTIBODY FORMATION. V. THE INFLUENCE OF ENDOTOXIN AND 5-FLUORO-2-DEOXYURIDINE ON THE PRIMARY ANTIBODY RESPONSE OF THE BALB MOUSE TO A PURIFIED PROTEIN ANTIGEN.

Authors: K MERRITT; A G JOHNSON
Journal: J Immunol Date: 1963-08 Impact factor: 5.422

2. The auto-immune hemolytic anemia of malignant lymphocytic disease.

Authors: M C ROSENTHAL; A V PISCIOTTA; Z D KOMNINOS; H GOLDENBERG; W DAMESHEK
Journal: Blood Date: 1955-03 Impact factor: 22.113

3. Homologous disease reactivation by x-radiation.

Authors: R S SCHWARTZ; L BELDOTTI
Journal: Science Date: 1963-04-12 Impact factor: 47.728

4. The loss of partial tolerance following sub-lethal irradiadition.

Authors: W H STONE; R D OWEN
Journal: Transplantation Date: 1963-01 Impact factor: 4.939

5. Autoimmune thrombocytopenic purpura ("ITP" type) with chronic lymphocytic leukemia.

Authors: S EBBE; B WITTELS; W DAMESHEK
Journal: Blood Date: 1962-01 Impact factor: 22.113

6. Specific homograft tolerance in lymphoid cells of long-lived radiation chimeras.

Authors: L J COLE; W E DAVIS
Journal: Proc Natl Acad Sci U S A Date: 1961-04-15 Impact factor: 11.205

7. Accelerated breakdown of immunological tolerance following whole body irradiation.

Authors: O MAKELA; G J NOSSAL
Journal: J Immunol Date: 1962-05 Impact factor: 5.422

8. Enhancement of antibody formation by whole body x-radiation.

Authors: F J DIXON; P J McCONAHEY
Journal: J Exp Med Date: 1963-05-01 Impact factor: 14.307

8 in total

12 in total

1. Autoimmune thrombocytopenia: a complication of fludarabine therapy in the treatment of Waldenstrom's macroglobulinemia.

Authors: Yujie Jiang; Hongjuan Peng; Xin Cui; Ying Zhou; Dai Yuan; Xiaohui Sui; Lingyan Zhang; Hongzhi Xu
Journal: Int J Clin Exp Med Date: 2014-12-15

Review 2. Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors: Clive S Zent; Neil E Kay
Journal: Best Pract Res Clin Haematol Date: 2010-03 Impact factor: 3.020

3. Autoimmunity in chronic lymphocytic leukaemia.

Authors: T J Hamblin; D G Oscier; B J Young
Journal: J Clin Pathol Date: 1986-07 Impact factor: 3.411

Review 4. A theory of the action of cancer chemotherapeutic drugs.

Authors: S Rose
Journal: Clin Exp Immunol Date: 1967-05 Impact factor: 4.330

5. [Irradiation as trigger or indicator of autoimmune hemolytic anemia in lymphocytic leukemia].

Authors: J Weinreich
Journal: Blut Date: 1967-11

6. [Autoimmune diseases].

Authors: H Begemann
Journal: Arch Klin Exp Ohren Nasen Kehlkopfheilkd Date: 1970

Review 7. Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors: T J Hamblin
Journal: Drugs Date: 2001 Impact factor: 9.546

Review 8. Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors: Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal: Haematologica Date: 2011-01-17 Impact factor: 9.941

9. Autoimmunity in chronic lymphocytic leukaemia.

Authors: M Lischner; M Prokocimer; A Zolberg; M Shaklai
Journal: Postgrad Med J Date: 1988-08 Impact factor: 2.401

10. Enhancement and inhibition of immunological mechanisms by immunosuppressive agents. I. Dose effect on priming and generation of memory to a bacterial antigen.

Authors: A J Macario; E Conway de Macario
Journal: Clin Exp Immunol Date: 1978-02 Impact factor: 4.330